Synlogic Reports First Quarter Financial Results and Provides Business Update

Synlogic Announces First Quarter 2021 Conference Call & Webcast

Synlogic Announces Pricing of Public Offering of Common Stock

Synlogic Announces Proposed Public Offering of Common Stock

Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting

Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting

Synlogic to Present at Upcoming Virtual Banking and Industry Conferences

Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria

Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast

Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team

Synlogic to Present at Upcoming Virtual Banking and Industry Conferences